Day Zero Diagnostics Wins Disruptive Technology Award at the 2021 AACC Annual Scientific Meeting

[ad_1]

News Image

Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to combat the rise of antibiotic-resistant infections, has won the 2021 Disruptive Technology Award from The American Association for Clinical Chemistry (AACC) and the Audience Choice Award.

AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. The Disruptive Technology Award recognizes innovative testing and disruptive technology solutions that improve patient care through diagnostic performance or access to high-quality testing. This year, the award was focused on artificial intelligence and machine learning technologies that are advancing medicine and pathology.

Jong Lee, President and CEO, presented the Day Zero technology, along with fellow finalists Mammoth Biosciences and MeMed, to a panel of expert judges at the 2021 AACC Annual Scientific Meeting which took place in Atlanta, GA. All presented testing solutions were judged on feasibility, data support, performance differentiation, and disruptive potential. In addition, Day Zero also won the Audience Choice award based on audience votes during the finalist competition.

“We are thrilled to be recognized by the AACC as a disruptive technology with the potential to transform patient care,” said Jong Lee, CEO of Day Zero Diagnostics. “The AACC represents the field of clinical laboratory medicine so its exceptionally rewarding to be selected by both the expert judges and the AACC conference attendees as a potentially transformative technology.”

Day Zero is pioneering a new class of culture-free, sequencing-based diagnostics that can modernize the fight against antibiotic-resistant infections. The company is developing a diagnostic system that promises to help patients with severe infections receive the most effective antibiotic treatment on the first day they are admitted to the hospital—day zero—rather than being treated with multiple days of toxic broad-spectrum antibiotics.

About Day Zero Diagnostics

Day Zero Diagnostics, Inc., based in Boston, is pioneering a new class of infectious disease diagnostics using whole-genome sequencing and machine learning to revolutionize how the world fights the growing threat of antibiotic resistance. The company’s mission is to change the way infectious diseases are diagnosed and treated by rapidly identifying both the species and the antibiotic resistance profile of severe infections without the need for a culture. By using sequencing, Day Zero also enables big data approaches for managing healthcare-associated infection outbreaks. Day Zero Diagnostics was founded in 2016 by a team of clinicians and scientists from Harvard University and Massachusetts General Hospital. The company has been recognized as a leading innovator by CARB-X, MedTech Innovator, TedMed Hive, Xconomy, HealthTech Arkansas, and MassChallenge HealthTech. For more information visit http://www.dayzerodiagnostics.com or follow us on Twitter at @dayzerodx.

Share article on social media or email:

[ad_2]

Mediaplanet and Samantha Harris Team Up to Launch Breast Cancer Awareness Month

[ad_1]

News Image

The one thing that I want to share with others is that the most important thing is to truly be your own advocate. We know our bodies better than anyone else.

Helping to kick off Breast Cancer Awareness Month, Mediaplanet today announces the launch of this September’s edition of “Breast Cancer Care.” This campaign looks to give power back to women by detailing real-life stories, addressing healthcare inequities, advocating for the importance of regular screening and early detection, and showcasing products that were created to help manage treatment side effects.

The American Cancer Society estimates that more than 280,000 women will be diagnosed with breast cancer in the United States this year, and the National Breast Cancer Foundation predicts that due to a delay of screenings and doctors’ visits because of the pandemic, there will no doubt be an increase in otherwise preventable later-stage diagnoses in the years to come.

Long-time breast cancer activist Samantha Harris graces the cover of the print publication. Through an exclusive interview on the interior, Samantha reveals that she discovered a lump in her breast just 11 days after a routine mammogram. “When I first heard the word cancer, I was absolutely floored and blindsided,” she reveals. Even though her OBGYN and internalist doctor said there was nothing to worry about, Harris trusted her gut and went to see a breast oncologist directly. There, she was diagnosed with stage II invasive breast cancer.

Now, Samantha says, “The one thing that I want to share with others is that the most important thing is to truly be your own advocate. We know our bodies better than anyone else.”

The print component of “Breast Cancer Care” is distributed within today’s edition of USA TODAY in Chicago, Los Angeles, Minneapolis, New York, and Washington DC/Baltimore markets, with a circulation of approximately 150,000 copies and an estimated readership of 450,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: https://www.futureofpersonalhealth.com/campaign/breast-health/

This campaign was made possible with the support of Eau Thermale Avene & AstraZeneca.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contact:

Danielle Elbert

Danielle.elbert@mediaplanet.com

Share article on social media or email:

[ad_2]

Stories of Survival,” A Groundbreaking Anti-Human Trafficking Documentary

[ad_1]

News Image

“Human trafficking is a form of modern slavery that denies freedom to over 40 million people worldwide each year. Despite its horrifically exploitative nature, it often goes unnoticed due to the perpetrators’ skill in enslaving their victims and the debilitating dependency and shame they feel.”

NEW YORK, New York, September 30, 2021 – The Salvation Army USA Eastern Territory today premiered its searing new anti-human-trafficking documentary, “Hope: Stories of Survival.” The film documents the story of three American women, Rachel, Tammy, and “T,” all of whom were sold for sex from as early as eight years old. They share their trauma of being trafficked over many years and the pain, despair, shame, and hopelessness they endured. They invite us to join them in their journeys of recovery and show us how they took back control of their destinies through empowerment, love, trust, and hope.

Arielle Curry, the Territorial Anti-Trafficking Coordinator for The Salvation Army USA Eastern Territory, noted: “Human trafficking is a form of modern slavery that denies freedom to over 40 million people worldwide each year. Yet, despite its horrifically exploitative nature, it often goes unnoticed due to the perpetrators’ skill in enslaving their victims and the debilitating dependency and shame that victims feel. This powerful documentary shines a bright light on the horrors of the exploitation that human trafficking victims experience. But it also offers a lesson in hope as Rachel, Tammy, and T share stories of their journeys from darkness to light.”

Forced human labor is a multi-billion dollar industry, with sex trafficking accounting for 81 percent of it. Of its millions of victims worldwide, 75 percent are women and girls. Tragically, 25 percent are children.

“The Salvation Army has been on the front lines of combatting human trafficking and helping its survivors for over a century. My team and I wanted to raise awareness of the issue and The Salvation Army’s anti-human-trafficking programs in an intimate yet impactful manner,” noted documentary director Joseph Pritchard, the Creative Services and Video Director for The Salvation Army USA Eastern Territory. “In Rachel, Tammy, and T, we found three courageous, generous, and inspiring women willing to share their journeys through trauma recovery and show us how they took back control of their lives through empowerment, trust, love, and hope. I want people who see this film to join The Salvation Army in raising awareness about the horrific realities of human trafficking and lend support to its victims. But, most of all, I want to share the message of HOPE that these women discovered during their recovery process and let victims and survivors know that they are not alone.”

“Hope: Stories of Survival” premieres at The Salvation Army Greater New York Division’s Centennial Memorial Temple on Thursday, September 30, 2021. After the premiere, there will be a panel discussion with the women in the documentary, anti-human-trafficking experts from The Salvation Army, and other organizations working together to combat human and sex trafficking. More information about the documentary is available at the website: https://hopefilm.org

About The Salvation Army: The Salvation Army annually helps more than 30 million Americans overcome poverty, addiction, and economic hardships through a range of social services. By providing food for the hungry, emergency relief for disaster survivors, rehabilitation for those suffering from drug and alcohol abuse, and clothing and shelter for people in need, The Salvation Army is doing the most good at 7,600 centers of operation around the country. During times of disaster, 100 percent of designated donations to The Salvation Army are used for immediate response and long-term efforts. In the first-ever listing of “America’s Favorite Charities” by The Chronicle of Philanthropy, The Salvation Army ranked as the country’s largest privately funded, direct-service nonprofit. For more information, visit http://www.SalvationArmyUSA.org. Follow us on Twitter @SalvationArmyUS and #DoingTheMostGood.

Share article on social media or email:

[ad_2]

PTS Diagnostics Announces Bridge Purchasing Solutions Joining The PreVantage™ Partnership Network

[ad_1]

PTS Diagnostics, a U.S.-based manufacturer of point-of-care medical testing devices, announced today that they have signed a strategic alliance agreement with Bridge Purchasing Solutions Inc.

“Bridge has built a very unique digital voucher platform that helps payors and businesses who have employees that need point-of-care testing to provide increased access while closing critical care gaps related to cardiovascular disease and diabetes,” said Steve Riendeau, Chief Commercial Officer of PTS Diagnostics. “As a result of the pandemic, many people have been unable to get important annual biometrics such as cholesterol and A1C testing. The Bridge platform allows electronic vouchers to be sent to an individual’s mobile phone where they can take it to a participating retail pharmacy to get the tests conducted. The platform also allows for seamless redemption of incentives which often accompany this testing. The PreVantage Partnership Network is focused on bringing companies together with a common mission of closing gaps in care for patients with chronic diseases and this is another opportunity for us to do so. PTS feels strongly that this strategic alliance is a great fit for our customers.”

PTS is a global leader in the production and distribution of point-of-care solutions. “It’s a privilege to be part of the PreVantage Network,” said Ken Erickson, CEO of Bridge Purchasing Solutions. “Our next generation B2B2E (Business to Business to Employee) fintech platform makes it possible to issue digital payment cards directly to an employee which can only be redeemed at the specified retail pharmacy partner. The frictionless payments, compliance reporting along with increased adherence are also keys to our future success. When combined with the world class products from PTS we are convinced our clients will embrace the solution.”

About PTS Diagnostics

PTS Diagnostics provides innovative, superior quality, point-of-care solutions. Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. Our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About Bridge Purchasing Solutions

Bridge, an innovative FinTech company, is on a mission to remove the barriers that hinder compliance with a healthy lifestyle including education, access, and cost. Bridge works with employers, health plans, and other health advocates to educate and drive employees and members to low-cost retail providers. The bridge platform can be used to drive compliance with health activities such as immunizations and biometric screenings, encourage healthy food choices, track ongoing management of at-risk members and deliver reward incentives in near real time. To find out how Bridge can help you and your organization achieve your healthcare goals vision Bridgepurchasingsolutions.com or email info@Bridgemart.com.

###

Press Contact:

Laurie Gutzwiller, Executive Director, Marketing

317-860-8070 – lgutzwiller@ptsdiagnostics.com

Share article on social media or email:

[ad_2]

SentientLight LLC Introduces the Sentient Element—The World’s Highest Intensity and most flexible PEMF Device

[ad_1]

PEMF Sentient Element Classic

Sentient Element Classic

“My life-changing experience inspired me to help people living with Lyme disease. I’m now dedicated to helping others with the Sentient Element, using my knowledge and talents. My mission is to make PEMF therapy effective, affordable and convenient for everyone,” said Langdon.

SentientLight LLC has launched the Sentient Element, one of the most powerful, affordable and portable PEMF devices that allows users in need of healing to choose from long, low-intensity sessions to short, deep penetrating high-intensity sessions or anything in-between. This facilitates cell healing and re-energization, detoxifies the body and helps the mind and body recover quickly. It is also an Iontophoresis machine.

“Back in 2000, I received a tick bite while hiking in the Cascade foothills just east of Seattle led to Lyme disease. Suffering from its typical progression that the conventional medical system had no answer for, and diagnosed with 12 co-infections, I got to the point of almost dying as the spirochetes (bacteria) became oral antibiotic resistant. Debilitated and in a wheelchair, I made a full recovery after 13 years, doggedly taking one small step in front of another,” said Larry Langdon, owner, chief engineer and developer of the Sentient Element.

Using his background in electrical engineering and programming, Larry began developing his own PEMF coiling device, the Ampcoil, based on the Doug Coil design—the result was the Sentient Element. Although driven by the desire to help Lyme sufferers, the PEMF machine has also been found to be helpful for all kinds of maladies as well as for general health improvement. It assists with muscle fatigue after exercise, supports general relaxation, optimizes wellness non-invasively, and enables users to experience more energy naturally.

Unlike most PEMF devices that only range from 1-50 Hz, the Sentient Element has a wide frequency range of 7-10,000 Hz. The dual coil design that offers twice the coverage of the pulsed electromagnetic field is among the most advanced. While intensity goes deep, the large surface area covers more parts of the body. Versatile and easy to use, the PEMF machine supports all waveforms and has unbeatable Power. SentientLight provides Discount coupons for Lyme sufferers, a 100% money back guarantee and a Lifetime Warranty are included.

“My life-changing experience inspired me to help people living with Lyme disease. I’m now dedicated to helping others with the Sentient Element, using my knowledge and talents. My mission is to make PEMF therapy effective, affordable and convenient for everyone,” said Langdon.

Research indicates that chronic, deep-seated health issues respond faster and better to high-intensity PEMF machines. The NIH studies prove this. PEMF therapy has been found to be safe, non-invasive and effective in several clinical scenarios to treat non-specific low back pain, patellofemoral pain syndrome, chronic post-operative pain, osteoarthritis-related pain, brain trauma, rheumatoid arthritis-related pain, and fibromyalgia-related pain. It may also alleviate chronic pain and fatigue in patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). In postoperative spinal surgery PEMF stimulation had higher rates of spinal fusion than control groups.

“I, myself, have been able to get completely off opiates (taken for over a year due to a severe back injury) because of the pain relief and nerve repair afforded me by using the Sentient Element. Likewise, it has helped diabetics, it has been able to reduce one’s intake of insulin, lower blood sugar numbers to near normal levels, and relieve neuropathy by ‘coiling,’” said Langdon.

For more information, visit https://www.sentientlight.com/

About SentientLight LLC

Larry Langdon founded SentientLight LLC in 2018. He has 30+ years of experience innovating cutting-edge technologies for Boeing, National Semiconductor, Intel, Microsoft and classified projects requiring special clearance for high-level applications. Utilizing his B.S. in electrical engineering, he has extensive experience in software, hardware, integration, instrumentation, product testing and embedded designs, including the first FDA approved defibrillator.

Contact

Name: Larry Langdon

Company: SentientLight LLC

Phone Number: 208-512-7775

Email: info@sentientlight.com

Website: https://www.sentientlight.com

Share article on social media or email:

[ad_2]

Pink Aid CT’s 2021 Auction Packs Chills and Thrills

[ad_1]

Stephanie Szostak to Appear in Pink Aid CT 2021 Event Video

Pink Aid, a Connecticut-based 501c3 charity formed in 2011, helps women survive breast cancer treatment with support and dignity, provides screening to women in financial need, and empowers breast cancer survivors to heal by helping and inspiring others.

Like many charities, Pink Aid CT has had to pivot this year to a virtual (we like to think, “virtuous”) event. No party, no masks, no overhead, but hundreds of exciting auction items for browsing and bidding beginning Tuesday, October 5th at 9 AM. In addition, an uplifting video release on October 7th at 8 PM will feature this year’s amazing guest host, Stephanie Szostak of ABC’s “A Million Little Things”, messages from Pink Aid’s founders (including our own Myra Kraft Community MVP, Amy Katz), and a our 2021 Warriors celebrating personal triumphs during breast cancer journeys. We’ll even reveal a pink surprise to help you keep the party going throughout the month of October.

This year’s auction is our greatest ever and has something for everyone from tee times at many of the region’s most exclusive golf clubs to luxury hotels, fashion, fine jewelry, gorgeous art, food & wine and some absolutely priceless experiences. Take the controls in a private plane. Or better yet, fly on Marc Lasry’s private jet to sit courtside and watch the 2021 NBA Champion Bucks show you how it’s done. Luxury escapes? Check. A private safari for 2 to Tanzania, trips to Palm Beach, the Keys or just stay local. Spend a night at The Baccarat Hotel or The Equinox NYC where you can stand right on The Edge and see the city like never before. Get your “Peaches” at Barclay’s with Justin Bieber or VIP seating at Christian Siriano’s Fall 2022 show with backstage passes and a meet & greet with the award-winning designer himself.

Best of all,100% of funds raised in this year’s auction go directly to Pink Aid programs that benefit women with breast cancer in underserved communities. Pink Aid, a Connecticut-based 501c3 charity formed in 2011, helps women survive breast cancer treatment with support and dignity, provides screening to women in financial need, and empowers breast cancer survivors to heal by helping and inspiring others.

Over the past decade, Pink Aid has granted more than $5.7 million throughout Connecticut to provide diagnostic testing, recovery and wellness programs, as well as outreach and education and emergency initiatives to breast cancer patients. What started as a local effort to provide compassion and screening to underserved breast cancer patients in Fairfield County has quickly grown to become a relied upon resource across the State, and most recently, beyond.

Created in 2015, Pink Aid’s Pink Purse Program provides direct emergency financial assistance to breast cancer patients undergoing treatment. Pink Purse pays for expenses including rent, mortgage, utilities, childcare, food and other essential needs – all with the goal of alleviating the stress of mounting financial burdens during an already difficult time. Transportation costs have been a big ask – and Pink Aid is incredibly grateful to the DARCARS Automotive Group for joining us as a corporate partner this year to address these needs specifically.

Our Pink Purse Program has granted more than $1,000,000 in emergency financial assistance to approximately 1,500 breast cancer patients. Patient applications in Connecticut have doubled in three years and on average the Pink Purse receives 30 applications monthly. It is important to note that Pink Purse pays all approved bills directly to service providers – usually within 48 hours – on behalf of each patient. In addition, each Pink Purse recipient receives a $100 Stop & Shop food card. During the pandemic, Pink Purse expanded its program to the rest of the country. To date, we have paid utility and transportation costs for women from 30 states and are seeing applications rise on a monthly basis.

To learn how you can GIVE HELP or GET HELP, or to register for our auction on October 5th, please visit http://www.pinkaid.org. Our organization is essentially all volunteer and has received a GuideStar Gold Rating.

Share article on social media or email:

[ad_2]

eClinical Solutions Drives Digital Clinical Evolution at elluminate Engage 2021 Conference

[ad_1]

“After such a pivotal and transformative year for life sciences, we look forward to gathering these leaders to discuss best practices for maximizing digital adoption and opportunities for novel approaches in the clinical and operational data lifecycle to accelerate clinical research.”

eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, will bring together life sciences innovators from around the world on Wednesday, November 3 and Thursday, November 4 for its third annual user conference, elluminate Engage 2021. The virtual event will focus on digital transformation in the life sciences industry, the acceleration of decentralized trial models and the elluminate® Clinical Data Cloud as a foundational technology for a future-proof drug development paradigm.

Scientist, entrepreneur, author and biotech investor Dr. Steve Gullans will deliver the Engage Keynote Address on November 3. An accomplished geneticist, he has published more than 130 scientific papers and held a faculty position at Harvard Medical School for nearly 20 years. Dr. Gullans is active in founding and directing life sciences companies to help refine strategies and accelerate growth, with a particular focus on the future of drug discovery. With a passion for innovation, he has spoken widely and is also the co-author of Evolving Ourselves, a book that examines how humans are impacting the course of evolution.

Joining Dr. Gullans on the first day of elluminate Engage is Nick Hargaden, Associate Director Clinical Systems at Agios Pharmaceuticals. Nick will talk about creating real-time visibility to trial and site performance and why this is important as life sciences organizations expand their pipelines in his session, “Leveraging elluminate for Operational Data.”

Also on Day 1 of the conference, eClinical CEO Raj Indupuri will follow his welcome address with a digital transformation and innovation discussion alongside Igor Proscurshim, Senior Medical Director at Takeda Oncology, and Biogen Vice President of Research and Development Greg Moody. Later, eClinical Solutions President and Co-Founder Bob Arnesen will moderate the panel, “Decentralized Clinical Trial (DCT) Models, Technology & Strategy: What you Need to Know Now,” which will will separate DCT hype from reality and and feature panelists Ian Shafer, Principal at PwC, Tom Sellig, CEO of LabConnect and Steven Lesser, Vice President Enterprise Solutions at Medable sharing how decentralized trial capabilities are playing out.

The second day of elluminate Engage includes a talk on “Solving Clinical Data Challenges” from Jazz Pharmaceuticals experts Megan Dunham, Sr. Manager, R&D Analytics and Vijay Koduru, Associate Director, Statistical Programming, highlighting the importance of interoperability for analytics, along with the elluminate Platform Roadmap and Vision session from eClinical leaders Sam Anwar and Rob Musterer, interactive Product Breakouts, and the panel, “Leveraging elluminate to Empower Clinical Teams in Emerging Biotechs,” with Rich Gleeson, Head of Clinical and R&D Technology, Cerevel Therapeutics and Ted Snyder, Director, Clinical Informatics, Praxis Precision Medicines.

“Life Sciences leaders are making incredible advances in science and are trailblazers in the application of technology to support modern digital clinical trials,” said Raj Indupuri, CEO of eClinical Solutions. “After such a pivotal and transformative year for life sciences, we look forward to gathering these leaders to discuss best practices for maximizing digital adoption and opportunities for novel approaches in the clinical and operational data lifecycle to accelerate clinical research.”

For more information about elluminate Engage and to see the agenda, please visit https://www.eclinicalsol.com/event/elluminate-engage-2021/

About eClinical Solutions LLC

eClinical Solutions helps life sciences organizations around the world accelerate their digital clinical initiatives. Our intelligent clinical data cloud and data services give our clients real-time, self-service access to all of their data from one centralized location; plus advanced analytics that promote smarter, faster business decisions. Find out more at eclinicalsol.com .

Media Contact:

Cameron Thomas for eClinical Solutions

(416) 660-9801

cameron@verbfactory.com

Share article on social media or email:

[ad_2]

Citeline Connect-Glooko Partnership Expands Clinical Trial Sponsors’ Ability to Recruit People with Diabetes for Medical Research

[ad_1]

Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence, has added Glooko to its patient recruitment collective, supported by the platform that brings together 75 vetted partners to simultaneously refer qualified patients to clinical trials. Glooko’s software platforms empower the management of diabetes and related conditions by collecting and unlocking the power of data, with access to over 35 billion data points globally, the largest in the world.

As the coronavirus pandemic has illustrated, diversity in clinical trials is increasingly important. Citeline Connect was chosen by two leading pharmaceutical companies to help quickly meet recruitment goals for diverse populations for COVID-19 vaccine trials. Diversity is particularly important for diabetes clinical trials; Hispanic individuals have higher levels of diabetes than the general population. According to the American Diabetes Association, Black Americans are 60% more likely to be diagnosed with diabetes than other groups. It is precisely these minorities who are underrepresented in clinical trials. Industry statistics show that while nearly 40% of Americans belong to an ethnic or racial minority, participants in clinical trials skew between 80% and 90% white.

Compounding the problem are ineffective pre-screening processes. Across disease states, 69% of patients fail to meet pre-screening criteria. According to one study of screen failure in diabetes clinical trials, renal inclusion criteria caused the most screen fails in Asians, whereas Blacks had the highest cardiovascular inclusion screen failure.

Citeline Connect features a robust pre-screening process. By partnering with Glooko — known for its remote patient monitoring solutions for diabetes and related chronic conditions such as obesity and hypertension — Citeline Connect will enhance pre-screening for these patients. Glooko’s technology supports over 200 devices, syncing with diabetes, fitness, biometric and other devices to capture real world data. It also integrates with the top EHR systems used in the industry.

Overall, for two consecutive years tracked by the Food and Drug Administration (FDA), the number of endocrinology, diabetes, and metabolism clinical trial participants declined considerably. In 2015, U.S. trials totaled 5,449, compared to 11,830 in the rest of the world. In 2016, the numbers plummeted to 665 in the U.S. and 4,063 elsewhere.

Citeline Connect, in conjunction with Glooko, is poised to reverse this trend by referring qualified diabetes patients to clinical trials. The Citeline Connect referral network is continually expanding to include organizations whose focus is on specific diseases and conditions. Other specialties include oncology, celiac and Crohn’s diseases, and psoriasis, as well as other rare diseases.

“At Citeline Connect, we are committed to helping clinical trial sponsors efficiently find — and recruit — the patients who specifically meet their inclusion and exclusion criteria,” said Mike Wenger, Vice President of Patient Engagement at Informa Pharma Intelligence. “While diabetes is a more common disease, this still can be like finding a needle in a haystack. That’s why we are expanding our patient recruitment collective with vetted partners such as Glooko that work like a magnet to attract those needles.”

“Glooko is very pleased to partner with Citeline Connect on this integration of our technologies,” said Russ Johannesson, CEO of Glooko. “At Glooko, we are proud to be the global leader in connected care for diabetes and adjacent chronic conditions like hypertension and obesity and are naturally leading the way for better remote data collection and management in connected clinical trials. Discovering new and novel therapeutics in pharma and medical devices is important in the quality of life and improved outcomes for patients with these conditions.”

For more information, visit https://www.citelineconnect.com or contact pharma@informa.com.

About Informa Pharma Intelligence

Citeline Connect, developed by Informa Pharma Intelligence, is the all-in-one clinical trial recruitment platform that accelerates trial enrollment via innovative technology and services. Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, powers a full suite of analysis products – including Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Biomedtracker™, Scrip™, Pink Sheet™ and In Vivo™ – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.

About Glooko

Glooko is transforming digital health by connecting people with diabetes and related conditions and their healthcare teams, enabling telehealth, clinical research, and improved collaboration. The company’s software platforms empower the management of diabetes and other chronic conditions by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, connected insulin pens, blood pressure cuffs, nutrition apps, connected weight scales and activity trackers – bringing insights together in one place. Data is easily uploaded – remotely via app or in-clinic, securely shared, and visualized in actionable charts and graphs. This creates a solid foundation enabling collaboration and confident treatment decisions. The platforms are compatible with over 95% of global diabetes devices along with health monitoring devices, giving people with diabetes and other chronic conditions and their care teams the freedom of choice. Over 3 million users have benefited from health data insights using Glooko’s solutions, which are trusted by world leaders in diabetes and chronic care, and used in 29 countries across 22 languages. Learn more at https://www.glooko.com.

Share article on social media or email:

[ad_2]

Amare Global Launches New Charity Program Benefiting The Children’s Center Utah

[ad_1]

News Image

“We are very passionate about the mental wellness of children. They are the future, and we must do our part as The Mental Wellness Company to invest in the next generation,” said Amare Global Founder & Chairman Hiep Tran.

Beginning September 16th, 2021, for every first order from new customers and partners, Amare will automatically round up the total of each order to the nearest dollar as a donation to The Children’s Center Utah. This is at no additional cost to the new customer or partner. The difference for the rounded-up amount will be paid out on behalf of Amare. Additionally, Amare’s existing customers and partners will also have the capability to round up their orders as a donation to support The Children Center Utah’s mission to enhance the emotional well-being of children and families.

“We are very passionate about the mental wellness of children. They are the future, and we must do our part as The Mental Wellness Company to invest in the next generation,” said Amare Global Founder & Chairman Hiep Tran. “We have launched our Round Up for Love program so that our community can partner with us to support this initiative as well. I believe we can make a massive difference in the mental wellness of children together.”

“I can’t think of a better reason to raise money than in support of children’s emotional well-being,” said Jared Turner, CEO of Amare Global and The Children’s Center Utah’s board member. “This year we wanted to reach further and elevate what it means to share the love by creating this new giving program and we are thrilled to be partnering with The Children’s Center Utah.”

The Children’s Center Utah offers clinical services such as assessment and evaluations, child and family therapy, and therapeutic preschool; as well as infant/early childhood mental health (IECMH) consultations and webinars for childcare professionals. Money donated through the Round Up For Love program will help ensure all children and families who need the center’s comprehensive mental health services can access them, regardless of their ability to pay.

“Our teams share a core value and that value is LOVE,” said Rebecca Dutson, president and CEO of The Children’s Center Utah. “These resources will support our team in providing best-in-class, trauma-informed, and evidence-based mental health services to children and families as well as training early childhood providers throughout the state. We look forward to a wonderful partnership with the Amare team to help us change the lives of the children and families we work with and to share our love for their well-being.” 

About The Children’s Center

Established in 1962, The Children’s Center Utah is the only organization in Utah exclusively offering trauma-informed, evidence-based treatment for very young children ages birth through six and their families. The Children’s Center Utah’s mission is to provide comprehensive mental health care to enhance the emotional well-being of infants, toddlers, preschoolers, and their families. As the regional experts in children’s mental health, The Children’s Center Utah offers individual and family therapy for mental and behavioral health challenges faced by young children, as well as treatment for trauma exposure. For more information, visit childrenscenterutah.org.

About Amare Global

Amare Global® (amare.com) was founded in 2016 as The Mental Wellness Company®. Its name, Amare, means “to love” in Latin. The company proudly proclaims its #1 core value is Love, and its mission is to create more love in the world. Amare is the category leader in the $121 billion market of mental wellness. Privately held and funded, it is one of the fastest-growing natural health products and direct selling companies. In addition, Amare empowers financial wellness through its entrepreneurial business opportunity. Its patented and award-winning product formulations leverage the emerging science of the gut microbiome, the body’s “second brain.” For more info, visit http://www.amare.com

Share article on social media or email:

[ad_2]

Rise Against Hunger Celebrates World Food Day 2021 With ‘Chef Showdown’ Cooking Competition

[ad_1]

News Image

Rise Against Hunger, the international hunger nonprofit organization, is hosting the It Starts With a Meal™️ Chef Showdown, a culinary ‘battle royale’ and virtual broadcast, on Friday, October 15 at 2 p.m. ET. Blending a passion for internationally inspired cuisine with an impactful purpose, this inaugural competition commemorates World Food Day, the annual holiday established by the United Nations to bring awareness to global food insecurity.

With Univision serving as the broadcast’s media partner, the Chef Showdown will be hosted by Chef Yisus, presenter on Univision’s Despierta América morning show and author of the COOK DELICIOUSLY WITH CHEF YISUS cookbook. Competitors JJ Johnson, a James Beard award-winning author of BETWEEN HARLEM & HEAVEN and New York restauranteur, and Ali Khan, known for Food Network’s Spring Baking Championship and Cheap Eats on the Cooking Channel, will debut dishes on camera inspired by countries Rise Against Hunger serves.

“As hunger relief is a cause I’m passionate about, being part of Rise Against Hunger’s Chef Showdown is very special to me,” said Chef Yisus. “I was born in Venezuela, and one of Rise Against Hunger’s global efforts has been to serve nutritious meals through its Hope for Venezuelan Refugee Project on the humanitarian route for those fleeing to nearby Colombia.”

In addition to being a good-spirited competition between renowned chefs, the Chef Showdown also helps fight global hunger. Voting, open now until the end of the broadcast, is conducted by supporters donating $10 or more to Rise Against Hunger through the web pages for JJ Johnson or Ali Khan. The chef who fundraises the highest amount will win the Golden Whisk Award, and the donations will enable Rise Against Hunger to continue serving children and families facing food insecurity. Through voting and event sponsorship donations, the Chef Showdown aims to raise $200,000 to support Rise Against Hunger’s work to address hunger, a critical issue exacerbated by the pandemic, in affected communities around the world. The funding raised through the event will allow Rise Against Hunger to extend its support to more than 2,600 people in 2021.

“The food industry and NGOs working to end hunger both have a shared understanding of the power of a meal on a person’s life,” said Barry Mattson, Rise Against Hunger’s CEO. “The Chef Showdown will showcase this connection, both through people voting for their favorite chef-created dish and through supporting Rise Against Hunger’s work to nourish lives globally. With rates of hunger increasing globally, taking action to support those affected is of the utmost importance, and tuning into this broadcast allows people to take action and make an impact virtually.”

The It Starts With a Meal™️ Chef Showdown is the latest in a series of successful broadcasts Rise Against Hunger has facilitated in recent years. Last year, the organization hosted Rise Against Hunger Goes Live, a 5-hour, telethon-style virtual event featuring educational updates and impact highlights, and the World Food Day Hour of Impact, which highlighted footage of the organization’s meal packaging events nationwide and allowed people to take action to end hunger by tuning in virtually.

###

About Rise Against Hunger

Rise Against Hunger, an international humanitarian organization, is growing a global movement to end hunger by empowering communities, nourishing lives and responding to emergencies. With locations across the U.S. and five international offices, the organization provides immediate nourishment for those facing hunger today and implements sustainable solutions that will lift entire communities for years to come. Rise Against Hunger has facilitated volunteer meal packaging of more than 540 million meals to be distributed to countries around the world. To find out more about Rise Against Hunger’s efforts to end hunger worldwide, please visit http://www.riseagainsthunger.org.

Share article on social media or email:

[ad_2]

Press Release News Wire Service